MEDIFAST (MED)
(Delayed Data from NYSE)
$19.53 USD
+0.69 (3.66%)
Updated Jul 25, 2024 03:52 PM ET
After-Market: $19.53 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MED 19.53 +0.69(3.66%)
Will MED be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for MED based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MED
Medifast (MED) Lags Industry in 3 Months: How to Play Ahead?
Medifast (MED) Tumbles More Than 40% in 3 Months: Here's Why
MED: What are Zacks experts saying now?
Zacks Private Portfolio Services
Medifast (MED) Q1 Earnings Miss Estimates, Revenues Fall Y/Y
Medifast's (MED) Transformation on Track Amid Macro Headwinds
MEDIFAST (MED) Down 11.5% Since Last Earnings Report: Can It Rebound?
Other News for MED
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024
Time to Unload: 3 Stocks in Deep Trouble to Sell Now
70 All Star And Graham Value Stocks: 56 Fit To Buy In July
D.A. Davidson Sticks to Its Sell Rating for Medifast (MED)
7 Consumer Staples Stocks to Buy at a 52-Week Low in July